tradingkey.logo

Enovis Corp

ENOV
22.360USD
-0.230-1.02%
收盘 02/09, 16:00美东报价延迟15分钟
699.03M总市值
亏损市盈率 TTM

Enovis Corp

22.360
-0.230-1.02%

关于 Enovis Corp 公司

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corp简介

公司代码ENOV
公司名称Enovis Corp
上市日期May 08, 2008
CEOMcdonald (Damien)
员工数量7367
证券类型Ordinary Share
年结日May 08
公司地址2711 Centerville Road
城市WILMINGTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编19808
电话13022529160
网址https://www.enovis.com/
公司代码ENOV
上市日期May 08, 2008
CEOMcdonald (Damien)

Enovis Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
113.85K
-666.00%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-325.00%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+6598.00%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+6598.00%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+6598.00%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+6598.00%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
10.52K
+6598.00%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
113.85K
-666.00%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-325.00%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+6598.00%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+6598.00%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+6598.00%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+6598.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
International Reconstructive
128.99M
23.50%
U.S. Reconstructive
128.98M
23.50%
U.S. Bracing & Support
126.98M
23.13%
International P&R
92.55M
16.86%
U.S. Other P&R
71.41M
13.01%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
International Reconstructive
128.99M
23.50%
U.S. Reconstructive
128.98M
23.50%
U.S. Bracing & Support
126.98M
23.13%
International P&R
92.55M
16.86%
U.S. Other P&R
71.41M
13.01%

股东统计

更新时间: 1月16日 周五
更新时间: 1月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.92%
The Vanguard Group, Inc.
11.19%
American Century Investment Management, Inc.
8.27%
Dimensional Fund Advisors, L.P.
4.86%
Rubric Capital Management LP
4.81%
其他
56.95%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.92%
The Vanguard Group, Inc.
11.19%
American Century Investment Management, Inc.
8.27%
Dimensional Fund Advisors, L.P.
4.86%
Rubric Capital Management LP
4.81%
其他
56.95%
股东类型
持股股东
占比
Investment Advisor
62.73%
Investment Advisor/Hedge Fund
29.67%
Hedge Fund
16.32%
Research Firm
4.93%
Individual Investor
1.67%
Bank and Trust
1.23%
Pension Fund
1.01%
Sovereign Wealth Fund
0.05%
Family Office
0.04%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
646
66.24M
115.83%
-9.74M
2025Q3
641
68.12M
128.26%
-1.19M
2025Q2
651
69.44M
130.24%
+2.07M
2025Q1
629
67.38M
125.09%
-4.06M
2024Q4
625
63.48M
125.04%
+1.28M
2024Q3
599
62.09M
124.13%
-57.94K
2024Q2
602
61.71M
121.92%
+2.05M
2024Q1
635
59.58M
125.47%
-9.23M
2023Q4
647
58.62M
120.02%
+2.97M
2023Q3
636
55.66M
121.59%
+429.23K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.96M
13.92%
-55.88K
-0.70%
Sep 30, 2025
The Vanguard Group, Inc.
6.49M
11.35%
+120.78K
+1.90%
Sep 30, 2025
American Century Investment Management, Inc.
4.73M
8.27%
-6.26K
-0.13%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.97M
5.2%
+51.20K
+1.75%
Sep 30, 2025
Rubric Capital Management LP
2.75M
4.81%
+2.75M
--
Sep 30, 2025
Davenport Asset Management
2.81M
4.91%
+50.85K
+1.85%
Sep 30, 2025
Dorsey Asset Management LLC
2.40M
4.2%
-153.86K
-6.03%
Sep 30, 2025
State Street Investment Management (US)
2.35M
4.11%
-138.65K
-5.57%
Sep 30, 2025
Hood River Capital Management LLC
1.73M
3.02%
-7.30K
-0.42%
Sep 30, 2025
River Road Asset Management, LLC
1.44M
2.52%
+1.06K
+0.07%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
State Street SPDR S&P Health Care Equipment ETF
1.83%
Invesco S&P SmallCap Health Care ETF
1.09%
Invesco S&P SmallCap 600 Pure Value ETF
0.45%
State Street SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.24%
iShares U.S. Medical Devices ETF
0.21%
Humankind US Stock ETF
0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
0.18%
Avantis US Small Cap Equity ETF
0.18%
Invesco S&P SmallCap 600 Revenue ETF
0.16%
查看更多
State Street SPDR S&P Health Care Equipment ETF
占比1.83%
Invesco S&P SmallCap Health Care ETF
占比1.09%
Invesco S&P SmallCap 600 Pure Value ETF
占比0.45%
State Street SPDR S&P 600 Small Cap Value ETF
占比0.25%
iShares S&P Small-Cap 600 Value ETF
占比0.24%
iShares U.S. Medical Devices ETF
占比0.21%
Humankind US Stock ETF
占比0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
占比0.18%
Avantis US Small Cap Equity ETF
占比0.18%
Invesco S&P SmallCap 600 Revenue ETF
占比0.16%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
公告日期
除权除息日
类型
比率
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
KeyAI